Skip to content
DraconiticResearch
Search Sources API
223,421 studies31 sourcesUpdated 5 min ago
Peer-reviewedLicence not statedFuture Medicinal Chemistry

Latest developments in small molecule inhibitors of cysteine protease B as antileishmanial drugs

  • Karla Joane da Silva Menezes1,2,3
  • Sonaly Lima Albino2,4
  • João Vitor Vieira da Silva2
  • Éric de Oliveira Rios2
  • Rafaella Alves da Silva Barbosa5
  • Juan D. Rodríguez-Macías6
  • Edgar Alexander Marquez Brazon7
  • Fátima Nogueira3
  • Sofia Cortes3
  • Ricardo Olimpio de Moura1,2
  • Igor José dos Santos Nascimento2,4,5,8
8 affiliations
  1. 1Programa de Pós-Graduação em Desenvolvimento e Inovação Tecnológica em Medicamentos (PPgDITM), Universidade Estadual da Paraíba (UEPB), Campina Grande, Brasil
  2. 2Laboratório de Desenvolvimento e Síntese de Fármacos (LDSF), Universidade Estadual da Paraíba (UEPB), Campina Grande, Brasil
  3. 3Global Health and Tropical Medicine (GHTM), Associate Laboratory in Translation and Innovation Towards Global Health (LA-REAL), Instituto de Higiene e Medicina Tropical (IHMT), Universidade NOVA de Lisboa (UNL), Lisboa, Portugal
  4. 4Programa de Pós-Graduação em Ciências Farmacêuticas, Departamento de Farmácia, Universidade Estadual da Paraíba, Campina Grande, Brasil
  5. 5Mestrado Profissional de Pesquisa em Saúde, Centro Universitário Cesmac, Maceió, Brasil
  6. 6Facultad de Ciencias de la Salud, Exactas y Naturales, Universidad Libre, Barranquilla, Colombia
  7. 7Facultad de Ciencias Básicas, Departamento de Química y Biología, Universidad del Norte, Barranquilla, Colombia
  8. 8Departamento de Farmácia, Centro Universitário Estácio de Alagoas, Maceió, Brasil
Read full textDOICite

Related

  1. Highlights in Cysteine Protease Inhibitors as Antiparasitic Agents Against Trypanosomatids
    Beatriz M. R. Querido, Maria do Céu Sousa, Jorge A. R. Salvador
    International Journal of Molecular SciencesPeer-reviewedCC BY 4.0Full textEpidemiology & public healthCrossrefEurope PMC
  2. Nitrile-Based Leishmania Cysteine Protease B Inhibitors with In Vivo Efficacy against Visceral Leishmaniasis
    Jhonatan Santos de Lima, Michele Ferreira da Silva Mela, Juliana Romano Lopes +15
    ACS OmegaPeer-reviewedCC BY 4.0Full textEpidemiology & public healthCrossrefDOAJPMC
  3. Design, synthesis, and antileishmanial evaluation of linker-diversified trimethoxyphenyl-1,2,4-triazole derivatives as folate pathway inhibitors of Leishmania major
    Ahmed E. Elsawi, Mohamed Abdelfadil, Tarfah Al-Warhi +5
    RSC Medicinal ChemistryPeer-reviewedPublisher termsFull textEpidemiology & public healthPMC
  4. The specific N-terminal sequence of rice phytocystatin OsCPI2 is the key domain for regulating its interaction with cysteine protease OsCysP7.
    Yue Zhang, Yingxue Sun, Mingbo Li +2
    BMC plant biologyPeer-reviewedCC BY-NC-NDFull text1 citedOncologyEurope PMCPMC
  5. Evaluation of 6-substituted coumarins as SARS-CoV-2 main protease inhibitors: enzymatic, cellular, and computational insights.
    Ashraf K El-Damasy, Md Sofequl Islam Mukim, Sangeun Jeon +7
    RSC advancesPeer-reviewedCC BYFull textInfectious diseaseEurope PMC

Cite

BibTeXRIS
BibTeX
@article{menezes2026latest,
  title = {{Latest developments in small molecule inhibitors of cysteine protease B as antileishmanial drugs}},
  author = {Karla Joane da Silva Menezes and Sonaly Lima Albino and João Vitor Vieira da Silva and Éric de Oliveira Rios and Rafaella Alves da Silva Barbosa and Juan D. Rodríguez-Macías and Edgar Alexander Marquez Brazon and Fátima Nogueira and Sofia Cortes and Ricardo Olimpio de Moura and Igor José dos Santos Nascimento},
  journal = {Future Medicinal Chemistry},
  year = {2026},
  month = aug,
  doi = {10.1080/17568919.2026.2714018},
  url = {https://doi.org/10.1080/17568919.2026.2714018},
}
RIS
TY  - JOUR
TI  - Latest developments in small molecule inhibitors of cysteine protease B as antileishmanial drugs
AU  - Karla Joane da Silva Menezes
AU  - Sonaly Lima Albino
AU  - João Vitor Vieira da Silva
AU  - Éric de Oliveira Rios
AU  - Rafaella Alves da Silva Barbosa
AU  - Juan D. Rodríguez-Macías
AU  - Edgar Alexander Marquez Brazon
AU  - Fátima Nogueira
AU  - Sofia Cortes
AU  - Ricardo Olimpio de Moura
AU  - Igor José dos Santos Nascimento
PY  - 2026
DA  - 2026/08/07
JO  - Future Medicinal Chemistry
DO  - 10.1080/17568919.2026.2714018
UR  - https://doi.org/10.1080/17568919.2026.2714018
SN  - 1756-8919
SN  - 1756-8927
ER  -